AAV8-α-Gal A gene therapy (Freeline Therapeutics)

N/A

Report date: 2026/01/26 11:06:22

Base Information

Drug NameAAV8-α-Gal A gene therapy (Freeline Therapeutics)
Drug Alias NameAdeno-associated viral vector serotype 8 containing the human alpha-galactosidase A gene
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of Actionα-Galactosidase modulators
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFreeline Therapeutics (Ireland) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFreeline Therapeutics (Ireland) Ltd
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A